Abstract:Summary Background This study aimed to: 1) assess the associations of biological age acceleration based on Klemera and Doubal's method (KDM-AA) with long-term risk of all-cause mortality; and 2) compare the association of KDM-AA with all-cause mortality among participants potentially at different stages of the cardiovascular disease (CVD) continuum. Methods The present study was based on a subpopulation of the China Kadoorie Biobank, with baseline survey during 2004–08. A total of 12,377 participants free of ischemic heart disease, stroke, or cancer at baseline were included, in which 8180 participants were identified to develop major coronary event (MCE), ischemic stroke (IS), intracerebral hemorrhage (ICH) or subarachnoid hemorrhage (SAH), and 4197 remained free of these cardiovascular diseases before 1 January 2014. These participants were followed up until 1 Jan 2018. KDM-AA was calculated by regressing biological age measurement, which was constructed based on baseline 16 physical and 9 biochemical markers using Klemera and Doubal's method, on chronological age. We estimated the associations of KDM-AA with the mortality risk using the hazard ratio (HR) and 95% confidence interval (CI) from Cox proportional hazard models. We assessed discrimination performance by Harrell's C-index and net reclassification index (NRI). Findings The participants who developed MCE (mean KDM-AA = 0.1 year, standard deviation [SD] = 1.6 years) or ICH/SAH (0.3 ± 1.5 years) during subsequent follow-up showed accelerated aging at baseline compared to those of IS (0.0 ± 1.2 years) and control (−0.3 ± 1.3 years) groups. The KDM-AA was positively associated with long-term risk of all-cause mortality (HR = 1.20; 95% CI: 1.17, 1.23), and the association was robust for participants potentially at different stages of the CVD continuum. Adding KDM-AA improved mortality prediction compared to the model only with sociodemographic and lifestyle factors in whole participants, with the Harrell's C-index increasing from 0.813 (0.807, 0.819) to 0.821 (0.815, 0.826) (NRI = 0.011; 95% CI: 0.003, 0.019). Interpretation In this middle-aged and elderly Chinese population, the KDM-AA is a promising measurement for biological age, and can capture the difference in cardiovascular health and predict the risk of all-cause mortality over a decade. Funding This work was supported by National Natural Science Foundation of China ( 82192904 , 82192901 , 82192900 , 81941018 ). The CKB baseline survey and the first re-survey were supported by a grant from the Kadoorie Charitable Foundation Hong Kong . The long-term follow-up is supported by grants from the UK Wellcome Trust ( 212946/Z/18/Z , 202922/Z/16/Z , 104085/Z/14/Z , 088158/Z/09/Z ), grants ( 2016YFC0900500 ) from the National Key R&D Program of China , National Natural Science Foundation of China ( 81390540 , 91846303 ), and Chinese Ministry of Science and Technology ( 2011BAI09B01 ).

Kidney-Qi Deficiency Diagnosed by Deng's Diagnosis Standard Was Not Correlated with Aging Based on Clinical Observation of 90 Participants

Prevalence and Related Factors of Chronic Kidney Disease (CKD) among Long-Lived Individuals (LLI) over 95 Years of Age.

Development and Validation of Two Composite Aging Measures Using Clinical Biomarkers in the Chinese Population

Urinary 8-hydroxydeoxyguanosine is a better biomarker of aging in non-smokers

The Theory of Deficiency of Kidney Caused Senescence

Clinical characteristics of the chronic kidney disease in the elderly: a cross-sectional study

Lipid Parameters and the Development of Chronic Kidney Disease: A Prospective Cohort Study in Middle-Aged and Elderly Chinese Individuals

Comparison of the Profiles of Patients Defined by Age-Adapted and Fixed Threshold CKD Criteria: a Nationwide, Cross-Sectional Study.

Relationships Between Traditional Chinese Medicine Constitution and Age-Related Cognitive Decline in Chinese Centenarians

Combined detection of urinary biomarkers noninvasively predicts extent of renal injury in patients with early diabetic kidney disease with kidney qi deficiency syndrome: A retrospective investigation

Association Between Metabolic Syndrome Components and Chronic Kidney Disease among 37,533 Old Chinese Individuals

Chinese observational prospective study of ageing population with chronic kidney disease (C-OPTION): a study protocol

Modeling biological age using blood biomarkers and physical measurements in Chinese adults

[Exploration on essence of spleen-kidney deficiency in middle-aged patients]

Co-differential genes between DKD and aging: implications for a diagnostic model of DKD

Kidney Function and Dementia Risk in Community-Dwelling Older Adults: the Shanghai Aging Study

Study on Prevention and Treatment of Kidney Deficiency and Bone Mineral Loss in Middle-Aged and Elderly Female Diabetes Patients

Epidemiological study of chronic kidney disease of centenarians in longevity area in China

Related factors on decreased activity of daily living in older patients with chronic kidney disease

High Prevalence and Associated Risk Factors for Impaired Renal Function and Urinary Abnormalities in A Rural Adult Population from Southern China

Age‐dependent changes in the gut microbiota and serum metabolome correlate with renal function and human aging